Stockscreener 앱 받기
11.74
0.84%
-0.10
Contineum Therapeutics Inc 주식(CTNM)의 최신 뉴스
Take Profit: Will Contineum Therapeutics Inc stock recover after earningsJuly 2025 Outlook & Weekly High Return Opportunities - baoquankhu1.vn
Aug Swings: Why Contineum Therapeutics Inc. stock attracts high net worth investorsJuly 2025 Gainers & Daily Momentum Trading Reports - Bộ Nội Vụ
Growth Review: Is Contineum Therapeutics Inc stock overvalued or fairly priced2025 Breakouts & Breakdowns & Weekly Top Gainers Alerts - baoquankhu1.vn
Market Recap: How interest rate cuts could boost Contineum Therapeutics Inc stock2025 Trading Volume Trends & Fast Entry High Yield Tips - Bộ Nội Vụ
Contineum Therapeutics stock drops as company prices upsized $90 million offering - MSN
Contineum Therapeutics Reports Phase 2 Trial Results - MSN
Why retail investors favor Contineum Therapeutics Inc. stockDip Buying & Safe Entry Point Identification - Улправда
What risks investors should watch in Contineum Therapeutics Inc. stockInflation Watch & Reliable Intraday Trade Alerts - Улправда
Contineum Therapeutics (NASDAQ:CTNM) Receives Equal Weight Rating from Morgan Stanley - Defense World
Contineum downgraded to Equal Weight from Overweight at Morgan Stanley - TipRanks
How interest rate cuts could boost Contineum Therapeutics Inc. stockJuly 2025 Setups & Safe Entry Trade Signal Reports - Улправда
What hedge fund activity signals for Contineum Therapeutics Inc. stockTrade Risk Report & AI Enhanced Execution Alerts - Улправда
How Contineum Therapeutics Inc. stock compares to market leaders2025 Market WrapUp & AI Driven Stock Movement Reports - Улправда
Stock Market Recap: How currency fluctuations impact Contineum Therapeutics Inc stock2025 Market Trends & Short-Term High Return Ideas - moha.gov.vn
Should I hold or sell Contineum Therapeutics Inc. stock in 2025July 2025 Closing Moves & Safe Entry Momentum Tips - Улправда
Setup Watch: How interest rate cuts could boost Contineum Therapeutics Inc. stockGold Moves & Weekly Top Performers Watchlists - Улправда
Can Contineum Therapeutics Inc. stock maintain operating marginsQuarterly Portfolio Report & Fast Moving Stock Trade Plans - ulpravda.ru
CTNM: Morgan Stanley Downgrades with Lowered Price Target | CTNM Stock News - GuruFocus
Contineum Therapeutics (NASDAQ:CTNM) Earns "Equal Weight" Rating from Morgan Stanley - MarketBeat
Morgan Stanley Downgrades Contineum Therapeutics to Equalweight From Overweight, Adjusts Price Target to $14 From $23 - marketscreener.com
Contineum Therapeutics stock downgraded by Morgan Stanley on IPF drug concerns - Investing.com Nigeria
What sentiment indicators say about Contineum Therapeutics Inc. stockSector Performance Review & Explosive Capital Gains - Улправда
Contineum Therapeutics, Inc. (CTNM) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Wall Street Analysts See a 91.49% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High? - Finviz
Lorrain, Contineum Therapeutics CSO, sells $51k in stock By Investing.com - Investing.com India
Lorrain, Contineum Therapeutics CSO, sells $51k in stock - Investing.com India
Contineum Therapeutics announces proposed $75M public offering - MSN
Contineum Therapeutics Submits Phase 2 Trial for PIPE-791 - MSN
Contineum Therapeutics Reports Increased R&D Investment Amid Losses - MSN
Contineum Therapeutics, Inc.(NasdaqGS: CTNM) added to NASDAQ Biotechnology Index - marketscreener.com
Aug Sentiment: Why Contineum Therapeutics Inc. stock is seen as undervaluedInflation Watch & Reliable Intraday Trade Alerts - Улправда
Contineum Therapeutics (NASDAQ:CTNM) Raised to Hold at Wall Street Zen - MarketBeat
Why analysts remain bullish on Contineum Therapeutics Inc. stockMarket Movers & Expert Approved Trade Ideas - Улправда
Why Contineum Therapeutics Inc. stock attracts high net worth investorsWeekly Trend Report & Free Long-Term Investment Growth Plans - Улправда
How risky is Contineum Therapeutics Inc. stock now2025 Trading Volume Trends & Low Risk Entry Point Tips - Улправда
Why Contineum Therapeutics Inc. stock is seen as undervaluedWeekly Profit Recap & Free Technical Pattern Based Buy Signals - Улправда
Published on: 2025-12-19 19:15:06 - Улправда
Why Contineum Therapeutics Inc. stock remains undervaluedEntry Point & Smart Money Movement Alerts - DonanımHaber
Aug Breakouts: Why Contineum Therapeutics Inc. stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - Улправда
Published on: 2025-12-19 11:46:29 - Улправда
Can Contineum Therapeutics Inc. stock deliver strong Q4 earnings2025 Geopolitical Influence & Safe Entry Point Identification - DonanımHaber
Contineum Therapeutics Earnings Notes - Trefis
EBITDA per share of Contineum Therapeutics, Inc. – NASDAQ:CTNM - TradingView — Track All Markets
Great Week for Contineum Therapeutics, Inc. (NASDAQ:CTNM) Institutional Investors After Losing 5.3% Over the Previous Year - 富途牛牛
4.73%
0.92%
자본화:
|
볼륨(24시간):